Baculovirus as an expression and/or delivery vehicle for vaccine antigens

References

• Kost TA, Condreay JP. Recombinant baculoviruses as expression vectors for insect and mammalian cells. Curr. Opin. Biotechnol.10, 428–433 (1999).
   PubMed Web of Science ®Google Scholar
• Summers MD. Milestones leading to the genetic engineering of baculoviruses as expression vector systems and viral pesticides. Adv. Virus Res.68, 3–73 (2006).
   PubMed Web of Science ®Google Scholar
• Cha HJ, Pham MQ, Rao G, Bentley WE. Expression of green fluorescent protein in insect larvae and its application for heterologous protein production. Biotechnol. Bioeng.56, 239–247 (1997).
   Google Scholar
• Maeda S. Expression of foreign genes in insects using baculovirus vectors. Ann. Rev. Entomol.34, 351–372 (1989).
   PubMed Web of Science ®Google Scholar
• Smith GE, Summers MD, Fraser MJ. Production of human β interferon in insect cells infected with a baculovirus expression vector. Mol. Cell. Biol.3, 2156–2165 (1983).
   PubMed Web of Science ®Google Scholar
• Laprise M-H, Grondin F, Dubois CM. Enhanced TGFβ1 maturation in high five cells coinfected with recombinant baculovirus encoding the convertase furin/pace: improved technology for the production of recombinant proproteins in insect cells. Biotechnol. Bioeng.58, 85–91 (1998).
   Google Scholar
• Fraser MJ. Expression of eukaryotic genes in insect cell cultures. In vitro Cell Dev. Biol.25, 225–235 (1989).
   Google Scholar
• Luckow VA, Summers MD. Trends in the development of baculovirus expression vectors. Bio/Technology6, 47–55 (1988).
   Web of Science ®Google Scholar
• van Oers MM. Vaccines for viral and parasitic diseases produced with baculovirus vectors. Adv. Virus Res.68, 193–253 (2006).
   PubMed Web of Science ®Google Scholar
• Crawford J, Wilkinson B, Vosnesensky A et al. Baculovirus-derived hemagglutinin vaccines protect against lethal influenza infections by avian H5 and H7 subtypes. Vaccine17, 2265–2274 (1999).
   PubMed Web of Science ®Google Scholar
• Treanor JJ, Wilkinson BE, Masseoud F et al. Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans. Vaccine19, 1732–1737 (2001).
   PubMed Web of Science ®Google Scholar
• Cox MM. Cell-based protein vaccines for influenza. Curr. Opin. Mol. Ther.7, 24–29 (2005).
   PubMed Web of Science ®Google Scholar
• Chackerian B. Virus-like particles: flexible platforms for vaccine development. Expert Rev. Vaccines6, 381–390 (2007).
   PubMed Web of Science ®Google Scholar
• Boisgerault F, Moron G, Leclerc C. Virus-like particles: a new family of delivery systems. Expert Rev. Vaccines1, 101–109 (2002).
   PubMedGoogle Scholar
• Ye L, Lin JG, Sun YL et al. Ebola virus-like particles produced in insect cells exhibit dendritic cell stimulating activity and induce neutralizing antibodies. Virology351, 260–270 (2006).
   PubMed Web of Science ®Google Scholar
• Grgacic EV, Anderson DA. Virus-like particles: passport to immune recognition. Methods40, 60–65 (2006).
   PubMed Web of Science ®Google Scholar
• Ramqvist T, Andreasson K, Dalianis T. Vaccination, immune and gene therapy based on virus-like particles against viral infections and cancer. Expert Opin. Biol. Ther.7, 997–1007 (2007).
   PubMed Web of Science ®Google Scholar
• Wang L, Zhuang H. Hepatitis E: an overview and recent advances in vaccine research. World J. Gastroenterol.10, 2157–2162 (2004).
   Web of Science ®Google Scholar
• Paavonen J, Jenkins D, Bosch FX et al. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a Phase III double-blind, randomised controlled trial. Lancet369, 2161–2170 (2007).
   PubMed Web of Science ®Google Scholar
• Cheshenko N, Krougliak N, Eisensmith RC, Krougliak VA. A novel system for the production of fully deleted adenovirus vectors that does not require helper adenovirus. Gene Ther.8, 846–854 (2001).
   PubMed Web of Science ®Google Scholar
• Hu Y-C. Baculovirus as a highly efficient expression vector in insect and mammalian cells. Acta Pharmacol. Sin.26, 405–416 (2005).
   PubMed Web of Science ®Google Scholar
• Bright RA, Carter DM, Daniluk S et al. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin. Vaccine25, 3871–3878 (2007).
   PubMed Web of Science ®Google Scholar
• Pushko P, Tumpey TM, Bu F et al. Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB/c mice. Vaccine23, 5751–5759 (2005).
   PubMed Web of Science ®Google Scholar
• Chung Y-C, Ho M-S, Wu J-C et al. Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge. Vaccine DOI:10.1016/j.vaccine.2008.01.058 (2008) (Epub ahead of print).
   Google Scholar
• Hu Y-C, Bentley WE. Effect of MOI ratio on the composition and yield of chimeric infectious bursal disease virus-like particles by baculovirus co-infection: deterministic predictions and experimental results. Biotechnol. Bioeng.75, 104–119 (2001).
   PubMed Web of Science ®Google Scholar
• Belyaev AS, Roy P. Development of baculovirus triple and quadruple expression vectors-coexpression of 3 or 4 bluetongue virus proteins and the synthesis of bluetongue virus-like particles in insect cells. Nucleic Acids Res.21, 1219–1223 (1993).
   PubMed Web of Science ®Google Scholar
• Bertolotti-Ciarlet A, Ciarlet M, Crawford SE, Conner ME, Estes MK. Immunogenicity and protective efficacy of rotavirus 2/6-virus-like particles produced by a dual baculovirus expression vector and administered intramuscularly, intranasally, or orally to mice. Vaccine21, 3885–3900 (2003).
   PubMed Web of Science ®Google Scholar
• Royall E, Woolaway KE, Schacherl J et al. The Rhopalosiphum padi virus 5´ internal ribosome entry site is functional in Spodoptera frugiperda 21 cells and in their cell-free lysates: implications for the baculovirus expression system. J. Gen. Virol.85, 1565–1569 (2004).
   PubMedGoogle Scholar
• Pijlman GP, Roode EC, Fan X et al. Stabilized baculovirus vector expressing a heterologous gene and GP64 from a single bicistronic transcript. J. Biotechnol.123, 13–21 (2006).
   PubMed Web of Science ®Google Scholar
• Chen YJ, Chen WS, Wu TY. Development of a bi-cistronic baculovirus expression vector by the Rhopalosiphum padi virus 5´ internal ribosome entry site. Biochem. Biophys. Res. Commun.335, 616–623 (2005).
   PubMedGoogle Scholar
• Wu TY, Wu CY, Chen YJ, Chen CY, Wang CH. The 5´ untranslated region of Perina nuda virus (PnV) possesses a strong internal translation activity in baculovirus-infected insect cells. FEBS Lett.581, 3120–3126 (2007).
   PubMed Web of Science ®Google Scholar
• Urakawa T, Ferguson M, Minor PD et al. Synthesis of immunogenic, but non-infectious poliovirus particles in insect cells by a baculovirus expression vector. J. Gen. Virol.70, 1453–1463 (1989).
   PubMed Web of Science ®Google Scholar
• Hu Y-C, Bentley WE, Edwards GH, Vakharia VN. Chimeric infectious bursal disease virus-like particles expressed in insect cells and purified by immobilized metal affinity chromatography. Biotechnol. Bioeng.63, 721–729 (1999).
   PubMed Web of Science ®Google Scholar
• Tjia ST, Altenschildesche GMZ, Doerfler W. Autographa californica nuclear polyhedrosis virus (AcNPV) DNA does not persist in mass cultures of mammalian cells. Virology125, 107–117 (1983).
   PubMed Web of Science ®Google Scholar
• Volkman LE, Goldsmith PA. in vitro study of Autographa californica nuclear polyhedrosis virus interaction with nontarget vertebrate host cells. Appl. Environ. Microbiol.45, 1085–1093 (1983).
   PubMed Web of Science ®Google Scholar
• Granados RR. Replication phenomena of insect viruses in vivo and in vitro. In: Safety Aspects of Baculoviruses as Biological Pesticides. Miltenburger HG (Ed.). Bundesministerium fur Forschung und Technologie, Bonn, Germany (1978).
   Google Scholar
• Carbonell LF, Klowden MJ, Miller LK. Baculovirus-mediated expression of bacterial genes in dipteran and mammalian cells. J. Virol.56, 153–160 (1985).
   PubMed Web of Science ®Google Scholar
• Carbonell LF, Miller LK. Baculovirus interaction with nontarget organisms: a virus-borne reporter gene is not expressed in two mammalian cell lines. Appl. Environ. Microbiol.53, 1412–1417 (1987).
   PubMed Web of Science ®Google Scholar
• Hofmann C, Sandig V, Jennings G et al. Efficient gene-transfer into human hepatocytes by baculovirus vectors. Proc. Natl Acad. Sci. USA92, 10099–10103 (1995).
   PubMed Web of Science ®Google Scholar
• Boyce FM, Bucher NLR. Baculovirus-mediated gene transfer into mammalian cells. Proc. Natl Acad. Sci. USA93, 2348–2352 (1996).
   PubMed Web of Science ®Google Scholar
• Kost TA, Condreay JP. Recombinant baculoviruses as mammalian cell gene delivery vectors. Trends Biotechnol.20, 173–180 (2002).
   PubMed Web of Science ®Google Scholar
• Kost TA, Condreay JP, Jarvis DL. Baculovirus as versatile vectors for protein expression in insect and mammalian cells. Nat. Biotechnol.23, 567–575 (2005).
   PubMed Web of Science ®Google Scholar
• Hu Y-C. Baculovirus vectors for gene therapy. Adv. Virus. Res.68, 287–320 (2006).
   PubMed Web of Science ®Google Scholar
• Hu Y-C. Baculovirus as gene transfer vectors. Curr. Gene Ther.8(1), 56–65 (2008).
   Google Scholar
• Pieroni L, Maione D, La Monica N. In vivo gene transfer in mouse skeletal muscle mediated by baculovirus vectors. Hum. Gene Ther.12, 871–881 (2001).
   PubMed Web of Science ®Google Scholar
• Airenne KJ, Hiltunen MO, Turunen MP et al. Baculovirus-mediated periadventitial gene transfer to rabbit carotid artery. Gene Ther.7, 1499–1504 (2000).
   PubMed Web of Science ®Google Scholar
• Mottershead D, van der Linden I, von Bonsdorff C-H, Keinanen K, Oker-Blom C. Baculoviral display of the green fluorescent protein and rubella virus envelope proteins. Biochem. Biophys. Res. Commun.238, 717–722 (1997).
   PubMed Web of Science ®Google Scholar
• Grabherr R, Ernst W, Oker-Blom C, Jones I. Developments in the use of baculoviruses for the surface display of complex eukaryotic proteins. Trends Biotechnol.19, 231–236 (2001).
   PubMed Web of Science ®Google Scholar
• Makela AR, Oker-Blom C. Baculovirus display: a multifunctional technology for gene delivery and eukaryotic library development. Adv. Virus Res.68, 91–112 (2006).
   PubMed Web of Science ®Google Scholar
• Condreay JP, Ames RS, Hassan NJ et al. Baculoviruses and mammalian cell-based assays for drug screening. Adv. Virus Res.68, 255–286 (2006).
   PubMed Web of Science ®Google Scholar
• Delaney WE, Isom HC. Hepatitis B virus replication in human HepG2 cells mediated by hepatitis B virus recombinant baculovirus. Hepatology28, 1134–1146 (1998).
   PubMed Web of Science ®Google Scholar
• Sollerbrant K, Elmen J, Wahlestedt C et al. A novel method using baculovirus-mediated gene transfer for production of recombinant adeno-associated virus vectors. J. Gen. Virol.82, 2051–2060 (2001).
   PubMed Web of Science ®Google Scholar
• Huang K-S, Lo W-H, Chung Y-C et al. Combination of baculovirus-mediated gene delivery and packed-bed reactor for scalable production of adeno-associated virus. Hum. Gene Ther.18, 1161–1170 (2007).
   Google Scholar
• Zeng J, Du J, Zhao Y, Palanisamy N, Wang S. Baculoviral vector-mediated transient and stable transgene expression in human embryonic stem cells. Stem Cells25, 1055–1061 (2007).
   PubMed Web of Science ®Google Scholar
• Ho Y-C, Lee H-P, Hwang S-M et al. Baculovirus transduction of human mesenchymal stem cell-derived progenitor cells: variation of transgene expression with cellular differentiation states. Gene Ther.13, 1471–1479 (2006).
   Google Scholar
• Sung L-Y, Lo W-H, Chiu H-Y et al. Modulation of chondrocyte phenotype via baculovirus-mediated growth factor expression. Biomaterials28, 3437–3447 (2007).
   PubMed Web of Science ®Google Scholar
• Chuang C-K, Sung L-Y, Hwang S-M et al. Baculovirus as a new gene delivery vector for stem cells engineering and bone tissue engineering. Gene Ther.14, 1417–1424 (2007).
   Google Scholar
• Chen H-C, Sung L-Y, Lo W-H et al. Combination of baculovirus-mediated BMP-2 expression and rotating-shaft bioreactor culture synergistically enhances cartilage formation. Gene Ther.15(4), 309–317 (2008).
   PubMed Web of Science ®Google Scholar
• Aoki H, Sakoda Y, Jukuroki K et al. Induction of antibodies in mice by a recombinant baculovirus expressing pseudorabies virus glycoprotein B in mammalian cells. Vet. Microbiol.68, 197–207 (1999).
   PubMed Web of Science ®Google Scholar
• Abe T, Takahashi H, Hamazaki H et al. Baculovirus induces an innate immune response and confers protection from lethal influenza virus infection in mice. J. Immunol.171, 1133–1139 (2003).
   PubMed Web of Science ®Google Scholar
• Facciabene A, Aurisicchio L, La Monica N. Baculovirus vectors elicit antigen-specific immune responses in mice. J. Virol.78, 8663–8672 (2004).
   PubMedGoogle Scholar
• Bai B, Lu X, Meng J et al. Vaccination of mice with recombinant baculovirus expressing spike or nucleocapsid protein of SARS-like coronavirus generates humoral and cellular immune responses. Mol. Immunol.45, 868–875 (2008).
   PubMed Web of Science ®Google Scholar
• Jarvis DL, Garcia A Jr. Biosynthesis and processing of the Autographa californica nuclear polyhedrosis virus gp64 protein. Virology205, 300–313 (1994).
   PubMedGoogle Scholar
• Boublik Y, Di Bonito P, Jones IM. Eukaryotic virus display: engineering the major surface glycoprotein of the Autographa californica nuclear polyhedrosis virus (AcNPV) for the presentation of foreign proteins on the virus surface. Biotechnology13, 1079–1084 (1995).
   PubMedGoogle Scholar
• Oomens AGP, Monsma SA, Blissard GW. The baculovirus gp64 envelope fusion protein – synthesis, oligomerization, and processing. Virology209, 592–603 (1995).
   Google Scholar
• Lindley KM, Su JL, Hodges PK et al. Production of monoclonal antibodies using recombinant baculovirus displaying gp64-fusion proteins. J. Immunol. Methods234, 123–135 (2000).
   Google Scholar
• Yoshida S, Kondoh D, Arai E et al. Baculovirus virions displaying Plasmodium berghei circumsporozoite protein protect mice against malaria sporozoite infection. Virology316, 161–170 (2003).
   Google Scholar
• Tami C, Peralta A, Barbieri R et al. Immunological properties of FMDV–gp64 fusion proteins expressed on SF9 cell and baculovirus surfaces. Vaccine23, 840–845 (2004).
   Google Scholar
• Chang YJ, Liu CYY, Chiang BL, Chao YC, Chen CC. Induction of IL-8 release in lung cells via activator protein-1 by recombinant baculovirus displaying severe acute respiratory syndrome-coronavirus spike proteins: identification of two functional regions. J. Immunol173, 7602–7614 (2004).
   Google Scholar
• Feng Q, Liu YY, Qu XX et al. Baculovirus surface display of SARS coronavirus (SARS-CoV) spike protein and immunogenicity of the displayed protein in mice models. DNA Cell Biol.25, 668–673 (2006).
   Google Scholar
• Yang D-G, Chung Y-C, Lai Y-K et al. Avian influenza virus hemagglutinin display on baculovirus envelope: cytoplasmic domain affects virus properties and vaccine potential. Mol. Ther.15, 989–996 (2007).
   PubMed Web of Science ®Google Scholar
• Lu L, Yu L, Kwang J. Baculovirus surface-displayed hemagglutinin of H5N1 influenza virus sustains its authentic cleavage, hemagglutination activity, and antigenicity. Biochem. Biophys. Res. Commun.358, 404–409 (2007).
   PubMed Web of Science ®Google Scholar
• Rahman MM, Shaila MS, Gopinathan KP. Baculovirus display of fusion protein of peste des petits ruminants virus and hemagglutination protein of rinderpest virus and immunogenicity of the displayed proteins in mouse model. Virology317, 36–49 (2003).
   PubMed Web of Science ®Google Scholar
• Barrett T. Recombinant DNA technology for producing new rinderpest virus vaccines. Expert Rev. Vaccines4, 113–120 (2005).
   PubMed Web of Science ®Google Scholar
• Strauss R, Huser A, Ni S et al. Baculovirus-based vaccination vectors allow for efficient induction of immune responses against Plasmodium falciparum circumsporozoite protein. Mol. Ther.15, 193–202 (2007).
   PubMed Web of Science ®Google Scholar
• Wang C-Y, Li F, Yang Y et al. Recombinant baculovirus containing the diphtheria toxin A gene for malignant glioma therapy. Cancer Res.66, 5798–5806 (2006).
   PubMed Web of Science ®Google Scholar
• Kim C-H, Yoon J-S, Sohn H-J et al. Direct vaccination with pseudotype baculovirus expressing murine telomerase induces anti-tumor immunity comparable with RNA-electroporated dendritic cells in a murine glioma model. Cancer Lett.250, 276–283 (2007).
   PubMed Web of Science ®Google Scholar
• Kitajima M, Abe T, Miyano-Kurosaki N et al. Induction of natural killer cell-dependent antitumor immunity by the Autographa californica multiple nuclear polyhedrosis virus. Mol. Ther.16(2), 261–268 (2008).
   Google Scholar
• Gronowski AM, Hilbert DM, Sheehan KCF, Garotta G, Schreiber RD. Baculovirus stimulates antiviral effects in mammalian cells. J. Virol.73, 9944–9951 (1999).
   PubMed Web of Science ®Google Scholar
• Hervas-Stubbs S, Rueda P, Lopez L, Leclerc C. Insect baculoviruses strongly potentiate adaptive immune responses by inducing type I IFN. J. Immunol.178, 2361–2369 (2007).
   PubMed Web of Science ®Google Scholar
• Abe T, Hemmi H, Miyamoto H et al. Involvement of the Toll-like receptor 9 signaling pathway in the induction of innate immunity by baculovirus. J. Virol.79, 2847–2858 (2005).
   PubMed Web of Science ®Google Scholar
• Raty JK, Liimatainen T, Huhtala T et al. SPECT/CT imaging of baculovirus biodistribution in rat. Gene Ther.14, 930–938 (2007).
   PubMed Web of Science ®Google Scholar
• Schutz A, Scheller N, Breinig T, Meyerhans A. The Autographa califomica nuclear polyhedrosis virus AcNPV induces functional maturation of human monocyte-derived dendritic cells. Vaccine24, 7190–7196 (2006).
   Google Scholar